Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Diabetic Macular Edema
Related studies linked through entity extraction aliases.
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
- Status
- COMPLETED
- Phase
- NA
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
- Status
- COMPLETED
- Phase
- N/A
Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study
- Status
- WITHDRAWN
- Phase
- PHASE4
A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema
- Status
- COMPLETED
- Phase
- N/A
Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
OCT-angiography in Diabetic Patients
- Status
- UNKNOWN
- Phase
- N/A
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE1
Adaptive Optics for Ophthalmic Technologies
- Status
- TERMINATED
- Phase
- NA
The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
Pain and Visual Outcome in Intravitreal Bevacizumab Injection
- Status
- COMPLETED
- Phase
- PHASE2
3 Month Outcome of Ziv-aflibercept for DME
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
- Status
- TERMINATED
- Phase
- PHASE4
Aflibercept in Recurrent or Persistent CNV
- Status
- RECRUITING
- Phase
- N/A